Contrast-Enhanced Whole-Heart Coronary Magnetic Resonance Angiography at 3.0-T: A Multicenter Trial

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01024478

Enrollment

272

Registered

2009-12-02

Start date

2009-10-31

Completion date

2010-09-30

Last updated

2011-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Coronary Artery, Magnetic Resonance Angiography, Coronary Artery disease, Multicenter Trial, Cardiac MRI

Brief summary

The multicenter study evaluates the diagnostic performance of 3.0 T contrast-enhanced whole-heart coronary MRA in patients with suspected coronary artery disease.

Detailed description

This is a multicenter trial evaluated the diagnostic ability of 3.0 T contrast-enhanced whole-heart coronary MRA to detect significant coronary artery stenosis among patients with suspected CAD. A total of 272 patients will be prospectively enrolled from 8 cities in China.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Suspected CAD, scheduled for DSA * Sinus rhythm

Exclusion criteria

* Contraindications to MR examination: pacemaker, intraauricular implants, intracranial clips, thoracotomy, claustrophobia, orthopnea * Acute coronary syndrome * Atria fibrillation * Coronary stents * Bypass grafts * Renal insufficiency (estimated glomerular filtration rate assessed by creatinine clearance \<60 ml/min/1.73 m2)

Countries

China

Outcome results